These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3792668)

  • 1. Gastric endocrine cells in omeprazole-treated and untreated patients with the Zollinger-Ellison syndrome.
    Bardram L; Thomsen P; Stadil F
    Digestion; 1986; 35 Suppl 1():116-22. PubMed ID: 3792668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells.
    Maton PN; Lack EE; Collen MJ; Cornelius MJ; David E; Gardner JD; Jensen RT
    Gastroenterology; 1990 Oct; 99(4):943-50. PubMed ID: 1697548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
    Hage E; Hendel L; Gustafsen J; Hendel J
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.
    Feurle GE
    Gut; 1994 Feb; 35(2):275-7. PubMed ID: 8307483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients.
    Delle Fave G; Marignani M; Corleto VD; Angeletti S; D'Ambra G; Ferraro G; D'Adda T; Azzoni C; Jensen RT; Annibale B; Bordi C
    Dig Liver Dis; 2002 Apr; 34(4):270-8. PubMed ID: 12038811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
    Hirschowitz BI; Haber MM
    Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal oxyntic gland atrophy with endocrine cell hyperplasia in Zollinger-Ellison syndrome during omeprazole treatment.
    Caruana P; Azzoni C; Bertelé A; Annibale B; Franzé A; Delle Fave G; Bordi C
    Histopathology; 1992 Oct; 21(4):359-63. PubMed ID: 1398539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis.
    Solcia E; Rindi G; Silini E; Villani L
    Baillieres Clin Gastroenterol; 1993 Mar; 7(1):149-65. PubMed ID: 7682874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome.
    Aprile MR; Azzoni C; Gibril F; Jensen RT; Bordi C
    Hum Pathol; 2000 Feb; 31(2):140-8. PubMed ID: 10685627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.
    Hirschowitz BI; Mohnen J; Shaw S
    Aliment Pharmacol Ther; 1996 Aug; 10(4):507-22. PubMed ID: 8853754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth.
    Creutzfeldt W; Lamberts R
    Digestion; 1992; 51 Suppl 1():76-81. PubMed ID: 1397748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypergastrinemia and gastric enterochromaffin-like cells.
    Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
    Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study.
    Maton PN; Vinayek R; Frucht H; McArthur KA; Miller LS; Saeed ZA; Gardner JD; Jensen RT
    Gastroenterology; 1989 Oct; 97(4):827-36. PubMed ID: 2777040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antisecretory drugs, hypergastrinemia and hyperplasia of enterochromaffin-like cells (ECL)].
    Andriulli A; Mangia A; Lawson F
    Minerva Gastroenterol Dietol; 1991; 37(3):135-40. PubMed ID: 1686409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
    Jensen RT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment.
    Lehy T; Mignon M; Cadiot G; Elouaer-Blanc L; Ruszniewski P; Lewin MJ; Bonfils S
    Gastroenterology; 1989 Apr; 96(4):1029-40. PubMed ID: 2925050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histomorphological characteristics of gastric mucosa in patients with Zollinger-Ellison syndrome or autoimmune gastric atrophy: role of gastrin and atrophying gastritis.
    Lehy T; Roucayrol AM; Mignon M
    Microsc Res Tech; 2000 Mar; 48(6):327-38. PubMed ID: 10738314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxyntic mucosa histology in omeprazole-treated patients suffering from duodenal ulcer or Zollinger-Ellison syndrome.
    Helander HF
    Digestion; 1986; 35 Suppl 1():123-9. PubMed ID: 3792669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereologic investigations of human gastric mucosa. II. Oxyntic mucosa from patients with Zollinger-Ellison syndrome.
    Helander HF; Rutgersson K; Helander KG; Pisegna JP; Gardner JD; Jensen RT; Maton PN
    Scand J Gastroenterol; 1992 Oct; 27(10):875-83. PubMed ID: 1439541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present experiences with omeprazole in the Zollinger-Ellison syndrome.
    Lamers CB
    Scand J Gastroenterol Suppl; 1986; 118():123-8. PubMed ID: 3460167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.